“Oral amoxicillin versus intravenous ampicillin for chest indrawing pneumonia in children aged 3–59 months: A randomized control trial”, Indian J Child Health, vol. 7, no. 8, pp. 332–336, Aug. 2020, doi: 10.32677/IJCH.2020.v07.i08.003.